argenx SE
(STU:1AE)
€
553.6
6 (1.1%)
Market Cap: 33.43 Bil
Enterprise Value: 30.56 Bil
PE Ratio: 0
PB Ratio: 8.44
GF Score: 82/100 argenx SE at Cowen Health Care Conference (Virtual) Transcript
Mar 07, 2022 / 07:10PM GMT
Release Date Price:
€241.9
(+0.67%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Well, good afternoon, everybody, and thank you once again for joining us for the 42nd Annual Cowen Healthcare Conference. It's a great pleasure to moderate the fireside chat today with argenx. I'm Yaron Werber, one of the biotech analysts here at Cowen, and I'm with my colleague, Brendan Smith, also on our team.
So it's a great pleasure to have with us, and they all need no introduction. Tim Van Hauwermeiren, who's the CEO of argenx; Keith Woods, Chief Operating Officer; and Karl Gubitz, who is the Chief Financial Officer.
So gentlemen, thank you for joining us. We appreciate it.
Timothy Van Hauwermeiren
argenx SE - CEO & Executive Director
Thanks for having us, Yaron. As always, it's a pleasure.
Questions & Answers
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
So we have a lot to talk about. So Tim, I know you've been
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot